MIT researchers are now turning the prolific Boltz series of models into a software company that promotes open science for AI-guided therapeutics.

Client programs using CHOMax follow platform-defined workflows and phase-appropriate practices across the development lifecycle.

Glioblastoma remains one of the most challenging solid tumors to treat due to its highly immunosuppressive tumor microenvironment.

Pancreatic organoids reveal how lumen shape is controlled by the balance between cell proliferation, internal pressure, and epithelial permeability.

Under the agreement, Bionova will serve as the preferred manufacturing partner for Syenex’s best-in-class delivery platforms.

In this eBook, we explore the pros and cons of emerging and traditional proteomics technologies in terms of coverage and detail.

This work not only identified the genetic cause of RP but also further highlights the role that noncoding genes can have in genetic disorders.

The map was developed by using single-cell RNA sequencing to analyze 1.4 million plasma and immune cells in bone marrow from over 300 patients.

Formerly Somite AI, the rebranded company aims to broaden the regenerative medicine landscape by building AI models that ...

Researchers say study findings may lead to a more promising future for cell therapy targeting stroke and other neurological disorders.

In this GEN webinar, our expert speakers will show how Nanoworx combines technical expertise with scalable workflows to support the seamless development of nanomedicines from early discovery and ...

GEN’s first virtual event of 2026—we present a group of outstanding researchers and thought-leaders to discuss the latest advances and challenges in delivering genetic therapies.